CORT
$50.39
Revenue | $182.55Mn |
Net Profits | $46.69Mn |
Net Profit Margins | 25.58% |
Corcept Therapeutics Inc’s revenue jumped 47.69% since last year same period to $182.55Mn in the Q3 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 11.45% jump in its revenue since last 3-months.
Corcept Therapeutics Inc’s net profit jumped 48.8% since last year same period to $46.69Mn in the Q3 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 31.57% jump in its net profits since last 3-months.
Corcept Therapeutics Inc’s net profit margin jumped 0.75% since last year same period to 25.58% in the Q3 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 18.05% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.28 |
EPS Estimate Current Year | 0.28 |
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.28 - a 21.74% jump from last quarter’s estimates.
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.28.
Earning Per Share (EPS) | 0.41 |
Corcept Therapeutics Inc’s earning per share (EPS) jumped 46.43% since last year same period to 0.41 in the Q3 2024. This indicates that the Corcept Therapeutics Inc has generated 46.43% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-07-29 | 0.23 | 0.32 | 39.13% |
2024-05-01 | 0.22 | 0.25 | 13.64% |
2024-10-30 | 0.28 | 0.41 | 46.43% |